RxDoctor Payments Data

Stacy Turner, APRN

Family · Annville, KYNPI 1053719310

Payments from drug & device makers

$517in general payments, 2019–2025

Across 30 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$184
  • UCB, Inc.$79
  • Novartis$68
  • Amgen$55
  • Lilly USA, LLC$30
  • E.r. Squibb & Sons, L.L.C.$26
  • plus $75 from 4 others

What the payments were for

  • Food & beverage$517100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$517 in reported general payments places this provider in the 50th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$826
Medicare patients
38
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab45$304,177
RinvoqUpadacitinib31$194,898
Enbrel SureclickEtanercept21$154,028
Orencia ClickjectAbatacept26$144,859
Cosentyx Sensoready (2 Pens)Secukinumab11$72,077
MounjaroTirzepatide21$21,825
OzempicSemaglutide16$15,181
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,362
JardianceEmpagliflozin14$8,961
RasuvoMethotrexate/Pf16$8,737
FarxigaDapagliflozin Propanediol11$7,442
Leflunomide116$6,524
SynthroidLevothyroxine Sodium28$1,583
Hydroxychloroquine Sulfate91$1,241
Nabumetone43$679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Synthroid$184$196,48159 claims
Lilly USA, LLCMounjaro$30$21,82521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,374 family providers in Kentucky.

Other family in Annville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →